期刊文献+

CD4^+CD25^+免疫调节性T细胞对CD4^+T细胞介导的移植物抗宿主病预防作用的研究 被引量:6

Prevention of CD4^+T cell-mediated graft-versus-host disease by CD4^+CD25^+T regulatory cells
下载PDF
导出
摘要 目的:研究CD4+CD25+免疫调节性T(Treg)细胞在小鼠骨髓移植后,对移植物抗宿主病的预防作用及其作用机制。方法:用C3H(H2k)小鼠骨髓作为供体,提取C3H(H2k)小鼠CD4+T及CD4+CD25+T细胞,C3H×B6(H2k/b)F1小鼠为骨髓移植的受者。在受者接受致死量全身放射后,输注供者去除T细胞的骨髓(ATBM),使其造血功能重建(ATBM组)。于不同的实验组给予CD4+(CD4组)T细胞,CD4+CD25+T(CD25组)或二者同时输注(CD4/CD25组)。观察各组小鼠移植物抗宿主病(GVHD)的发生率。结果:所有10只ATBM组小鼠至骨髓移植后60天仍全部存活,无GVHD发生;所有10只CD4组小鼠在骨髓移植10天内全部死于GVHD(P<0.01);所有5只CD25组小鼠于骨髓移植后60天仍全部存活,无明显GVHD发生(P>0.05);同样,所有6只CD4/CD25组小鼠至骨髓移植后仍全部存活,无明显GVHD发生(P>0.05)。结论:在同种异基因小鼠的骨髓移植模型中,CD4+CD25+T不诱导GVHD的发生,并有预防CD4+T细胞介导的GVHD发生的作用。 Objective:To investigate if CD4^+ CD25^+ regrating T cells can suppress GVHD mediated by CD4^+ T cells in mufine semi-allogeneic bone marrow transplantation model and try to figure out the mechanisms evolved. Methods:C3H (H-2k) as donors, C3H x B6 (H-2k/b) F1 (recipients) were lethally irradiated and reconstituted with antibody T cell depleted bone marrow( ATBM), and divided into 4 groups : ( A ) No further treatment ( n = 10 ) ; ( B ) Infused 5 x 10^5 C3 H CD4^+ T cells ( CD4, n = 10 ) ; ( C ) Infused 5 × 10^5 CD46+ CD25^+ Treg( CD25, n = 5 ) ; (D) Infused 5 × 105 CD4^+ T cells plus 5 × 105 CD4^+ CD25^+ Treg ( CD4/CD25, n = 6 ). Results : All mice in ATBM group, CD25 group and CD4/CD25 groups survived until 60 days without any GVHD symptoms, while all mice in CD4 group died in 10 days from GVHD. Conclusion : CD4^+ CD25^+ Treg cells did not cause GVHD and can prevent GVHD mediated by CD4 ^+ cells while co-injected with CD4^+ T cells.
作者 韩梅 王冠军
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2006年第4期323-326,共4页 Chinese Journal of Immunology
关键词 CD4^+CD25^+TREG 骨髓移植 GVHD CD^4+ CD25^+ T regulatory cells Bone marrow transplantation Graft-versus-host disease
  • 相关文献

参考文献14

  • 1Sakaguchi S, Sakaguchi N, Asano M et al. Immunologic self-tolerance maintained by activated T ceils expressing IL-2 receptor alphachains( CD25 ). Breakdown of a single mechanism of self-tolerance cause various autoimmune diseases [ J ]. J lmmunol, 1995; 155 (3)1151-1164.
  • 2Thornton A M, Shevach E M. CD4^+ CD25^+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting inter-leukin 2 production [J]. J Exp Med, 1998; 188(2) :287-296.
  • 3Sakaguchi S, Sakaguchi N, Shimizu Jet al. Immunologic tolerance maintained by CD4^+ CD25^+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance [J]. Immunol Rev, 2001; 182:18-32.
  • 4Liyanage U K, Moore T T, Joo H Get al. Prevalence of regulatory T cells is increased in peripheral blood and tumor micro-environment of patients with pancreas or breast adenocarcinma [ J ]. J lmmunol,2002 ; 169 (5) :2756-2761.
  • 5Takahashi T, Kuniyasu Y, Toda Met al. Immunologic self tolerance maintained by CD4^+ CD25^+ naturally anergic and suppressive T cells : induction of autoimmune disease by breaking their anergic/suppressive state [ J ]. lnt lmmunol, 1998 ; 10 : 1969-1980.
  • 6Salomon B, Lenschow D J, Rhee L et al. B7/CD28 costimulation is essential for the homestasis of the CD4^+ CD25^+ immunoregulatory T cells that control autoimmune diabetes [J]. lmmnity, 2000; 12:431-440.
  • 7Sakaguchi S. Animal models of autoimmunity and their relevance to human diseases [J]. Curr Opin lmmunol, 2000; 12:684-690.
  • 8Singh B S, Read C, Asseman Vet 02. Control of intestinal inflammation by regulatory T cells [J].Immunol Rev, 2001 ; 182:190-200.
  • 9Shevach E M, McHugh R R, Piccirillo C A et al. Control of T-cell activation by CD4^+ CD25^+ suppressor T ceils [ J ].Immunol Rev,2001 ; 182:58-67.
  • 10Thornton A M, Shevach E. Suppressor effector function of CD4^+ CD25^+ immunoregulatory T cell is antigen nonspecitic [J].Immunol, 2000;164:183-190.

同被引文献68

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部